During the past decade, University of Nebraska Medical Center-Hematology/Oncology Section conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Nebraska Medical Center-Hematology/Oncology Section" #1 collaborator was "Astex Pharmaceuticals, Inc." with 1 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "University of Nebraska Medical Center-Hematology/Oncology Section" are "Acute Lymphocytic Leukemia" (1 trials), "Acute Myelogenous Leukemia" (1 trials), "Alzheimer Disease" (1 trials), "Alzheimer's Disease" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "University of Nebraska Medical Center-Hematology/Oncology Section" in a lesser frequency.

Most popular intervention types in "University of Nebraska Medical Center-Hematology/Oncology Section" are "Drug" (6 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "AV-101" (1 trials), "Aducanumab" (1 trials), "Autologous stem cell transplant" (1 trials) and "BEAM" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Nebraska Medical Center-Hematology/Oncology Section" are 6 trials for "All" genders.

Currently, there are NaN active trials in "University of Nebraska Medical Center-Hematology/Oncology Section". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of Nebraska Medical Center-Hematology/Oncology Section, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Nebraska Medical Center-Hematology/Oncology Section, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".